Drugmakers Sanofi-Aventis U.S. Inc. and Sanofi-Aventis U.S. LCC will pay up to $109 million in a settlement over an alleged scheme to provide doctors with free units of its knee-injection drug Hyalgan...
Please login or register first to view this content.
Login Register